Ian A. Pilcher
FDA investigator
Appears on 2 documents from 2015 to 2016, mostly at sites in California. Most often cites design controls (21 CFR 820.30(c)).
- 2
- Documents on file
- 3.0
- Observations per 483
- 2015
- First seen
- 2016
- Most recent
What they cite most
From 6 observations- 21 CFR 820.30(c)Design controls4
- 21 CFR 56.103Circumstances in which IRB review is required1
- 21 CFR 820.40(a)Document controls1
Activity by year
2015: 1, 2016: 1
Where
California 2
Often inspects with
Is Ian A. Pilcher coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2016-08-18 | 483 Theranos, Inc.Aug 18, 2016 · Palo Alto, California | Palo Alto, California | 1 | |
| 2015-09-16 | 483 Theranos, Inc.Sep 16, 2015 · Palo Alto, California | Palo Alto, California | 5 |
About this profile
What does Ian A. Pilcher inspect?
Ian A. Pilcher appears on 2 documents on file covering 1 site, mostly in California.
What do they cite most often?
21 CFR 820.30(c) (design controls), followed by 21 CFR 56.103 and 21 CFR 820.40(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Ian A. Pilcher is dated Aug 18, 2016.